SynthesisBlood2015
Value of innovation in hematologic malignancies: a systematic review of published cost-effectiveness analyses.
Cayla J Saret et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this paperpooled itcites it